Royalty Pharma plc Annual Net Cash Provided by (Used in) Financing Activities in USD from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Royalty Pharma plc annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2024.
  • Royalty Pharma plc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$212M, a 0.77% decline year-over-year.
  • Royalty Pharma plc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $361M.
  • Royalty Pharma plc annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$2.15B, a 127% decline from 2022.
  • Royalty Pharma plc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$945M, a 345% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $361M +$2.51B Jan 1, 2024 Dec 31, 2024 10-K 2025-02-12
2023 -$2.15B -$1.2B -127% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-12
2022 -$945M -$1.33B -345% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-12
2021 $385M -$1.1B -74.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $1.49B +$2.68B Jan 1, 2020 Dec 31, 2020 10-K 2023-02-15
2019 -$1.19B +$187M +13.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-15
2018 -$1.38B Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.